AIMS: Fabry disease (FD) is a multisystemic lysosomal storage disorder caused by a defect in the alpha-galactosidase A gene that manifests as a phenocopy of hypertrophic cardiomyopathy. We assessed the echocardiographic 3D left ventricular (LV) strain of patients with FD in relation to heart failure severity using natriuretic peptides, the presence of a cardiovascular magnetic resonance (CMR) late gadolinium enhancement scar, and long-term prognosis. METHODS AND RESULTS: 3D echocardiography was feasible in 75/99 patients with FD [aged 47 ± 14 years, 44% males, LV ejection fraction (EF) 65 ± 6% and 51% with hypertrophy or concentric remodelling of the LV]. Long-term prognosis (death, heart failure decompensation, or cardiovascular hospitalization) was assessed over a median follow-up of 3.1 years. A stronger correlation was observed for N-terminal pro-brain natriuretic peptide levels with 3D LV global longitudinal strain (GLS, r = -0.49, P < 0.0001) than with 3D LV global circumferential strain (GCS, r = -0.38, P < 0.001) or 3D LVEF (r = -0.25, P = 0.036). Individuals with posterolateral scar on CMR had lower posterolateral 3D circumferential strain (CS; P = 0.009). 3D LV-GLS was associated with long-term prognosis [adjusted hazard ratio 0.85 (confidence interval 0.75-0.95), P = 0.004], while 3D LV-GCS and 3D LVEF were not (P = 0.284 and P = 0.324). CONCLUSION: 3D LV-GLS is associated with both heart failure severity measured by natriuretic peptide levels and long-term prognosis. Decreased posterolateral 3D CS reflects typical posterolateral scarring in FD. Where feasible, 3D-strain echocardiography can be used for a comprehensive mechanical assessment of the LV in patients with FD.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital U nemocnice 2 Prague 2 128 02 Czech Republic

Radiology Department 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Eur Heart J Cardiovasc Imaging. 2023 Nov 23;24(12):1638-1639. doi: 10.1093/ehjci/jead164. PubMed

Zobrazit více v PubMed

Ortiz  A, Germain  DP, Desnick  RJ, Politei  J, Mauer  M, Burlina  A  et al.  Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab  2018;123:416–27. PubMed

Desnick  RJ, Brady  R, Barranger  J, Collins  AJ, Germain  DP, Goldman  M  et al.  Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med  2003;138:338–46. PubMed

Pieroni  M, Moon  JC, Arbustini  E, Barriales-Villa  R, Camporeale  A, Vujkovac  AC  et al.  Cardiac involvement in Fabry disease: JACC review topic of the week. J Am Coll Cardiol  2021;77:922–36. PubMed

Linhart  A, Lubanda  JC, Palecek  T, Bultas  J, Karetová  D, Ledvinová  J  et al.  Cardiac manifestations in Fabry disease. J Inherit Metab Dis  2001;24(Suppl. 2):75–83; discussion 65. PubMed

Perry  R, Shah  R, Saiedi  M, Patil  S, Ganesan  A, Linhart  A  et al.  The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease. JACC Cardiovasc Imaging  2019;12:1230–42. PubMed

Rob  D, Marek  J, Dostalova  G, Linhart  A. Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations. ESC Heart Fail  2022;9:4043–52. PubMed PMC

Linhart  A, Germain  DP, Olivotto  I, Akhtar  MM, Anastasakis  A, Hughes  D  et al.  An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail  2020;22:1076–96. PubMed

Lang  RM, Badano  LP, Tsang  W, Adams  DH, Agricola  E, Buck  T  et al.  EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging  2012;13:1–46. PubMed

Muraru  D, Niero  A, Rodriguez-Zanella  H, Cherata  D, Badano  L. Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovasc Diagn Ther  2018;8:101–17. PubMed PMC

Nabeshima  Y, Seo  Y, Takeuchi  M. A review of current trends in three-dimensional analysis of left ventricular myocardial strain. Cardiovasc Ultrasound  2020;18:23. PubMed PMC

Luis  SA, Yamada  A, Khandheria  BK, Speranza  V, Benjamin  A, Ischenko  M  et al.  Use of three-dimensional speckle-tracking echocardiography for quantitative assessment of global left ventricular function: a comparative study to three-dimensional echocardiography. J Am Soc Echocardiogr  2014;27:285–91. PubMed

Kleijn  SA, Brouwer  WP, Aly  MFA, Rüssel  IK, de Roest  GJ, Beek  AM  et al.  Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function. Eur Heart J Cardiovasc Imaging  2012;13:834–9. PubMed

Seo  Y, Ishizu  T, Enomoto  Y, Sugimori  H, Yamamoto  M, Machino  T  et al.  Validation of 3-dimensional speckle tracking imaging to quantify regional myocardial deformation. Circ Cardiovasc Imaging  2009;2:451–9. PubMed

Beck  M. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl  2006;95:43–6. PubMed

Kasahara  S, Sakata  Y, Nochioka  K, Miura  M, Abe  R, Sato  M  et al.  Conversion formula from B-type natriuretic peptide to N-terminal proBNP values in patients with cardiovascular diseases. Int J Cardiol  2019;280:184–9. PubMed

Cockcroft  DW, Gault  MH. Prediction of creatinine clearance from serum creatinine. Nephron  1976;16:31–41. PubMed

Levey  AS, Stevens  LA, Schmid  CH, Zhang  YL, Castro  AF, Feldman  HI  et al.  A new equation to estimate glomerular filtration rate. Ann Intern Med  2009;150:604–12. PubMed PMC

Lang  RM, Badano  LP, Mor-Avi  V, Afilalo  J, Armstrong  A, Ernande  L  et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging  2015;16:233–70. PubMed

Galderisi  M, Esposito  R, Schiano-Lomoriello  V, Santoro  A, Ippolito  R, Schiattarella  P  et al.  Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study. Eur Heart J Cardiovasc Imaging  2012;13:730–8. PubMed

Shanks  M, Thompson  RB, Paterson  ID, Putko  B, Khan  A, Chan  A  et al.  Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr  2013;26:1407–14. PubMed

Voilliot  D, Huttin  O, Hammache  N, Filippetti  L, Vaugrenard  T, Aliot  E  et al.  Impact of global and segmental hypertrophy on two-dimensional strain derived from three-dimensional echocardiography in hypertrophic cardiomyopathy: comparison with healthy subjects. J Am Soc Echocardiogr  2015;28:1093–102. PubMed

Spinelli  L, Giugliano  G, Imbriaco  M, Esposito  G, Nappi  C, Riccio  E  et al.  Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease. Int J Cardiovasc Imaging  2020;36:1465–76. PubMed

Lu  D-Y, Huang  W-M, Wang  W-T, Hung  S-C, Sung  S-H, Chen  C-H  et al.  Reduced global longitudinal strain as a marker for early detection of Fabry cardiomyopathy. Eur Heart J Cardiovasc Imaging  2022;23:487–95. PubMed

Esposito  R, Galderisi  M, Santoro  C, Imbriaco  M, Riccio  E, Maria Pellegrino  A  et al.  Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients. Eur Heart J Cardiovasc Imaging  2019;20:438–45. PubMed

Krämer  J, Niemann  M, Liu  D, Hu  K, Machann  W, Beer  M  et al.  Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J  2013;34:1587–96. PubMed

Thorstensen  A, Dalen  H, Hala  P, Kiss  G, D’hooge  J, Torp  H  et al.  Three-dimensional echocardiography in the evaluation of global and regional function in patients with recent myocardial infarction: a comparison with magnetic resonance imaging. Echocardiography  2013;30:682–92. PubMed

Morris  DA, Blaschke  D, Canaan-Kühl  S, Krebs  A, Knobloch  G, Walter  TC  et al.  Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status. Int J Cardiovasc Imaging  2015;31:301–13. PubMed

Medvedofsky  D, Maffessanti  F, Weinert  L, Tehrani  DM, Narang  A, Addetia  K  et al.  2D and 3D echocardiography-derived indices of left ventricular function and shape: relationship with mortality. JACC Cardiovasc Imaging  2018;11:1569–79. PubMed PMC

Medvedofsky  D, Lang  RM, Weinert  L, Tehrani  DM, Narang  A, Mor-Avi  V. 3D echocardiographic global longitudinal strain can identify patients with mildly-to-moderately reduced ejection fraction at higher cardiovascular risk. Int J Cardiovasc Imaging  2019;35:1573–9. PubMed

Zada  M, Lo  Q, Boyd  AC, Bradley  S, Devine  K, Denaro  CP  et al.  Basal segmental longitudinal strain: a marker of subclinical myocardial involvement in Anderson-Fabry disease. J Am Soc Echocardiogr  2021;34:405–413.e2. PubMed

de Knegt  MC, Fuchs  A, Weeke  P, Møgelvang  R, Hassager  C, Kofoed  KF. Optimisation of coronary vascular territorial 3D echocardiographic strain imaging using computed tomography: a feasibility study using image fusion. Int J Cardiovasc Imaging  2016;32:1715–23. PubMed